20-Jan-2026 6:00 AM CST - Business Wire 908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced preliminary unaudited financial results for the quarter and full year ended December 31, 2025. Preliminary unaudited revenue for the fourth quarter of 2025 is approximately $17.2 million, compared to $14.3 million in the fourth quarter of 2024, reflecting reported gro
10-Nov-2025 6:00 AM CST - Business Wire 908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended September 30, 2025. We are pleased with our year-to-date progress as we continue to build a more predictable and profitable business and bring our 908 Devices 2.0 vision to life, said Kevin J. Knopp, CEO and Co-founder. Revenue for the f
30-Oct-2025 6:00 AM CST - Business Wire 908 Devices to Participate in Upcoming Investor Conferences 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will participate in the following investor conferences. Stifel Healthcare Conference, New York, NY Fireside chat on Wednesday, November 12 at 8:40 a.m. Eastern Time 27th Annual Stephens Investment Conference, Nashville, TN Fireside chat on Thursday, November 20 at 10 a.m. Cen
22-Oct-2025 6:00 AM CST - Business Wire 908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will report financial results for the third quarter 2025 before market open on Monday, November 10, 2025. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available
5-Aug-2025 6:00 AM CST - Business Wire 908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook #VipIR--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended June 30, 2025. We executed with urgency and discipline in the second quarter, driving strong top-line growth while advancing key structural initiatives to strengthen our financial profile, said Kevin J. Knopp, CEO and Co-founder. We deli
29-Jul-2025 6:00 AM CST - Business Wire 908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming Canaccord Genuity 45th Annual Growth Conference. 908 Devices management is scheduled to present on Wednesday, August 13 at 1 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the Investors section
22-Jul-2025 6:00 AM CST - Business Wire 908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will report financial results for the second quarter 2025 before market open on Tuesday, August 5, 2025. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available o
22-May-2025 6:00 AM CST - Business Wire 908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming William Blair 45th Annual Growth Stock Conference. 908 Devices management is scheduled to present on Wednesday, June 4 at 4 p.m. Central Time / 5 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on th
13-May-2025 6:00 AM CST - Business Wire 908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook 908 Devices Inc. (Nasdaq: MASS) a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended March 31, 2025. We are off to a strong start in 2025, with first-quarter revenue exceeding our expectations and the transformation to 908 Devices 2.0 already delivering both top-line growth and meaningful cost reductions, said Kevin J. Kno
20-Jan-2026 6:00 AM CST - Business Wire 908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced preliminary unaudited financial results for the quarter and full year ended December 31, 2025. Preliminary unaudited revenue for the fourth quarter of 2025 is approximately $17.2 million, compared to $14.3 million in the fourth quarter of 2024, reflecting reported gro
10-Nov-2025 6:00 AM CST - Business Wire 908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended September 30, 2025. We are pleased with our year-to-date progress as we continue to build a more predictable and profitable business and bring our 908 Devices 2.0 vision to life, said Kevin J. Knopp, CEO and Co-founder. Revenue for the f
30-Oct-2025 6:00 AM CST - Business Wire 908 Devices to Participate in Upcoming Investor Conferences 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will participate in the following investor conferences. Stifel Healthcare Conference, New York, NY Fireside chat on Wednesday, November 12 at 8:40 a.m. Eastern Time 27th Annual Stephens Investment Conference, Nashville, TN Fireside chat on Thursday, November 20 at 10 a.m. Cen
22-Oct-2025 6:00 AM CST - Business Wire 908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will report financial results for the third quarter 2025 before market open on Monday, November 10, 2025. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available
5-Aug-2025 6:00 AM CST - Business Wire 908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook #VipIR--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended June 30, 2025. We executed with urgency and discipline in the second quarter, driving strong top-line growth while advancing key structural initiatives to strengthen our financial profile, said Kevin J. Knopp, CEO and Co-founder. We deli
29-Jul-2025 6:00 AM CST - Business Wire 908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming Canaccord Genuity 45th Annual Growth Conference. 908 Devices management is scheduled to present on Wednesday, August 13 at 1 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the Investors section
22-Jul-2025 6:00 AM CST - Business Wire 908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will report financial results for the second quarter 2025 before market open on Tuesday, August 5, 2025. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available o
22-May-2025 6:00 AM CST - Business Wire 908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming William Blair 45th Annual Growth Stock Conference. 908 Devices management is scheduled to present on Wednesday, June 4 at 4 p.m. Central Time / 5 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on th
13-May-2025 6:00 AM CST - Business Wire 908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook 908 Devices Inc. (Nasdaq: MASS) a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended March 31, 2025. We are off to a strong start in 2025, with first-quarter revenue exceeding our expectations and the transformation to 908 Devices 2.0 already delivering both top-line growth and meaningful cost reductions, said Kevin J. Kno
